Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/03/1999US5932554 Prevent binding of toxins to receptors
08/03/1999US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease
08/03/1999US5932548 Lysine containing peptides for treatment of heart disease
08/03/1999US5932541 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-l-histidyl-l-prolinam ide or a pharmaceutically acceptable salt thereof
08/03/1999US5932465 Phosphodiesterase 8A
08/03/1999US5932427 In vitro assay system for identifying compositions useful for stimulating B cells
08/03/1999US5932259 Basic peptide fraction is obtained by hydrolyzing the basic protein fraction with a protease. useful for treating or preventing bone diseases such as osteoporosis.
08/03/1999US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema
08/03/1999US5932208 Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
08/03/1999CA2182101C Neuroprotective compounds
08/03/1999CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine
07/1999
07/29/1999WO1999037790A1 Human calcineurin b-like protein
07/29/1999WO1999037772A1 Il-18 receptors
07/29/1999WO1999037760A1 Inhibition of cytokine production
07/29/1999WO1999037753A1 Enzyme catalyzed therapeutic agents
07/29/1999WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037649A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037648A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037647A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037646A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037645A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037644A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
07/29/1999WO1999037637A1 Benzamide derivatives as vasopressin antagonists
07/29/1999WO1999037625A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
07/29/1999WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof
07/29/1999WO1999037621A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
07/29/1999WO1999037619A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037618A1 Phenylalanine derivatives useful as pharmaceutical agents
07/29/1999WO1999037617A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
07/29/1999WO1999037614A1 Azetidinecarboxamide derivatives for the treatment of cns disorders
07/29/1999WO1999037613A1 Azetidinecarboxamide derivatives for treating cns disorders
07/29/1999WO1999037611A1 Heterocyclic amidines as callicrein protease inhibitors
07/29/1999WO1999037335A1 Apparatuses and processes for whole-body hyperthermia
07/29/1999WO1999037325A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
07/29/1999WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use
07/29/1999WO1999037304A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
07/29/1999WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
07/29/1999WO1999037294A2 Mitochondria protecting agents for treating mitochondria associated diseases
07/29/1999WO1999037289A1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
07/29/1999WO1999002162A9 Cyclin dependent kinase inhibiting purine derivatives
07/29/1999CA2319131A1 Mitochondria protecting agents for treating mitochondria associated diseases
07/29/1999CA2319121A1 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer
07/29/1999CA2319109A1 Meth1 and meth2 polynucleotides and polypeptides
07/29/1999CA2319077A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318952A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999CA2318303A1 Secreted proteins and polynucleotides encoding them
07/29/1999CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
07/29/1999CA2318100A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318088A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2317920A1 Human calcineurin b-like protein
07/29/1999CA2317839A1 Inhibition of cytokine production
07/29/1999CA2317546A1 2,3,4,5-tetrahydro-1h-¬1,4|-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
07/29/1999CA2317486A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999CA2317484A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999CA2317422A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999CA2315763A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999CA2315213A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/28/1999EP0931788A2 Metalloprotease inhibitors
07/28/1999EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products
07/28/1999EP0931547A1 Piperazinyl-heterocyclic compounds in the treatment of psychiatric conditions
07/28/1999EP0931544A2 NF-kB activity inhibitor
07/28/1999EP0931159A2 Non-mammalian dna virus having an altered coat protein
07/28/1999EP0931156A2 Gene expression and delivery systems and uses
07/28/1999EP0931149A2 A novel haemopoietin receptor and genetic sequences encoding same
07/28/1999EP0931147A1 ANTI-ErbB2 ANTIBODIES
07/28/1999EP0931144A1 Novel human phospholemman-like protein
07/28/1999EP0931096A2 HT m4?, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
07/28/1999EP0931092A2 Variants of vascular endothelial cell growth factor having antagonistic properties
07/28/1999EP0931087A1 Novel pyranoside derivatives
07/28/1999EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use
07/28/1999EP0931084A1 1,3-dicarboxylic germanium complex and its therapeutic use
07/28/1999EP0931081A1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
07/28/1999EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
07/28/1999EP0931067A1 D4 receptor selectivity piperazine derivatives
07/28/1999EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
07/28/1999EP0931060A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
07/28/1999EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses
07/28/1999EP0930889A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
07/28/1999EP0930885A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
07/28/1999EP0930878A1 Use of sodium 2-mercaptoethanesulfonate in surgery
07/28/1999EP0930831A1 Flavonol containing food supplements
07/28/1999EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
07/28/1999EP0766665B1 Metalloproteinase inhibitors
07/28/1999EP0705265B1 Novel chemical compounds having pde-iv inhibition activity
07/28/1999EP0604494B1 5-ht4 receptor antagonists
07/28/1999CN1224464A Growth factor and genetic sequence encoding same
07/28/1999CN1224424A Azolobenzazepine derivs. as neurologically active agents
07/28/1999CN1224357A Aqueous formulations of peptides
07/28/1999CN1224356A Non-aqueous protic peptide formulations
07/28/1999CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
07/27/1999US5929249 Angiotensin ii receptor antagonists
07/27/1999US5929247 Heterocyclic compounds and their preparation and use
07/27/1999US5929237 Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; for random drug screening
07/27/1999US5929236 2-substituted morpholine and thiomorpholine derivatives as GABA-B antagonists
07/27/1999US5929213 Antibodies to growth differentiation factor-12
1 ... 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 ... 1564